Status:
COMPLETED
Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia III
Lead Sponsor:
PROCEPT BioRobotics
Conditions:
Benign Prostatic Hyperplasia
Eligibility:
MALE
40-85 years
Phase:
NA
Brief Summary
A dual-arm prospective, interventional clinical trial to evaluate the safety and performance of obtaining hemostasis with catheters along with the use or absence of a hemostatic agent following treatm...
Detailed Description
PROCEPT BioRobotics has developed the AQUABEAM, a personalized image-guided waterjet resection system that utilizes a high-pressure saline stream to resect and remove prostate tissue in males sufferin...
Eligibility Criteria
Inclusion
- Male
- BPH symptoms
Exclusion
- Serious concurrent medical conditions
Key Trial Info
Start Date :
July 18 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2018
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT04308070
Start Date
July 18 2017
End Date
June 30 2018
Last Update
March 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Muljibhai Patel Urological Hospital
Nadiād, Gujarat, India, 387001